Nitroglycerin
Product Images NDC 62175-123

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 62175-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nitroglycerin 01)

Chemical structure diagram showing the molecular arrangement of nitroglycerin, with three nitrate groups connected via carbon atoms.*

FDA Label Image

Figure (Nitroglycerin 02)

An instructional diagram showing the layered structure of a Nitroglycerin adhesive patch. The layers include a peelable protective liner, a Nitroglycerin/adhesive matrix, and an impermeable foil backing, with an arrow indicating removal of the liner.*

FDA Label Image

Figure (Nitroglycerin 03)

Illustration showing a close-up of hands demonstrating the opening of a foil blister pack containing a single tablet or pill, highlighting how to peel back the foil to access the medication inside.*

FDA Label Image

Figure (Nitroglycerin 04)

An instructional illustration showing hands peeling apart the backing of a patch, likely demonstrating how to open or prepare a transdermal patch for application, associated with Nitroglycerin by Lannett Company, Inc.*

FDA Label Image

Figure (Nitroglycerin 05)

An instructional illustration showing a person applying a medication patch to the upper chest area just below the collarbone. The figure is a simplified line drawing focusing on the hand placement of the patch application.*

FDA Label Image

Principal Display Panel (30 Patch Carton)

Packaging label for Nitroglycerin Transdermal System 0.2 mg/hr (10 cm²) by Lannett Company, Inc. The label states contents include 30 systems and highlights each 10 cm² unit contains 20.8 mg nitroglycerin with an approximate release of 0.2 mg/hr for transdermal use only. Instructions for patient use, storage, and cautionary notes are included along with an NDC number 62175-123-01 and a barcode.*

FDA Label Image

Principal Display Panel (30 Patch Carton)

Packaging label for Nitroglycerin Transdermal System 0.4 mg/hr (18 cm²) by Lannett Company, Inc. The label shows a box for 30 transdermal systems with instructions for application and storage. It states that each 18 cm² patch contains 37.4 mg nitroglycerin in an acrylic-based polymer adhesive delivering approximately 0.4 mg/hr in vivo. The label includes patient instructions, dosage information, and a space for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.